140 related articles for article (PubMed ID: 10660129)
1. Genetic changes in sweat gland carcinomas.
Takata M; Hashimoto K; Mehregan P; Lee MW; Yamamoto A; Mohri S; Ohara K; Takehara K
J Cutan Pathol; 2000 Jan; 27(1):30-5. PubMed ID: 10660129
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
4. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins.
Ohki K; Kumamoto H; Ichinohasama R; Suzuki M; Yamaguchi T; Echigo S; Motegi K; Ooya K
Int J Oral Maxillofac Surg; 2001 Dec; 30(6):538-44. PubMed ID: 11829237
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?
El-Naggar AK; Callender D; Coombes MM; Hurr K; Luna MA; Batsakis JG
Genes Chromosomes Cancer; 2000 Feb; 27(2):162-8. PubMed ID: 10612804
[TBL] [Abstract][Full Text] [Related]
8. Adnexal carcinomas of the skin. I. Eccrine carcinomas.
Wick MR; Goellner JR; Wolfe JT; Su WP
Cancer; 1985 Sep; 56(5):1147-62. PubMed ID: 2990667
[TBL] [Abstract][Full Text] [Related]
9. [Eccrine sweat gland carcinoma of the skin].
Rütten A
Pathologe; 2002 Jan; 23(1):79-88. PubMed ID: 11974507
[TBL] [Abstract][Full Text] [Related]
10. Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications.
el-Naggar AK; Hurr K; Kagan J; Gillenwater A; Callender D; Luna MA; Batsakis JG
Am J Surg Pathol; 1997 Jun; 21(6):691-7. PubMed ID: 9199647
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in sweat gland tumors.
Biernat W; Woźniak L
Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
[TBL] [Abstract][Full Text] [Related]
12. Genetic changes and histopathological grades in human hepatocellular carcinomas.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in sweat gland carcinomas.
Biernat W; Peraud A; Wozniak L; Ohgaki H
Int J Cancer; 1998 May; 76(3):317-20. PubMed ID: 9579565
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome.
Entius MM; Keller JJ; Westerman AM; van Rees BP; van Velthuysen ML; de Goeij AF; Wilson JH; Giardiello FM; Offerhaus GJ
J Clin Pathol; 2001 Feb; 54(2):126-31. PubMed ID: 11215281
[TBL] [Abstract][Full Text] [Related]
18. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cellular proliferation of eccrine acrospiromas and eccrine sweat gland carcinomas by AgNOR counting and immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) and Ki-67.
Ansai S; Koseki S; Hozumi Y; Kondo S
Clin Exp Dermatol; 1995 Jan; 20(1):27-34. PubMed ID: 7671392
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma): analysis of four cases.
Kawano R; Takeshima Y; Inai K
Pathol Int; 1996 Jan; 46(1):38-45. PubMed ID: 10846548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
